GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $312,000 | +11.8% | 2,987 | +84.7% | 0.25% | +35.7% |
| Q2 2019 | $279,000 | -24.8% | 1,617 | -26.6% | 0.18% | -11.9% |
| Q1 2019 | $371,000 | -22.9% | 2,203 | -36.1% | 0.21% | +37.3% |
| Q2 2018 | $481,000 | +11.9% | 3,446 | +5.8% | 0.15% | +21.4% |
| Q4 2017 | $430,000 | -13.5% | 3,256 | -33.6% | 0.13% | -10.6% |
| Q3 2017 | $497,000 | +3.3% | 4,900 | +2.1% | 0.14% | -15.1% |
| Q2 2017 | $481,000 | – | 4,800 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |